Aberrant hedgehog signaling and clinical outcome in osteosarcoma

Sarcoma

Volumn 2014, Issue , 2014, Pages

  Lo, Winnie W ^a,b   Pinnaduwage, Dushanthi ^b   Gokgoz, Nalan ^b   Wunder, Jay S ^a,b,c   Andrulis, Irene L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN PATCHED 1; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; MALE; OSTEOSARCOMA; OUTCOME ASSESSMENT; PRIMARY TUMOR; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 84899485183     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2014/261804     Document Type: Article

References (35)

1. Levesque J., Marx R., Bell R. S., Winder J. S., Kandel R. A., White L. M., A Clinical Guide to Primary Bone Tumors 1998 Philadelphia, Pa, USA Williams & Wilkins
2. Link M. P., Goorin A. M., Miser A. W., The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. The New England Journal of Medicine 1986 314 25 1600 1606 2-s2.0-0022656434 (Pubitemid 16118216)
3. Eilber F., Giuliano A., Eckhardt J., Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. Journal of Clinical Oncology 1987 5 1 21 26 2-s2.0-0023125939 (Pubitemid 17007852)
4. Bielack S. S., Kempf-Bielack B., Delling G., Exner G. U., Flege S., Helmke K., Kotz R., Salzer-Kuntschik M., Wemer M., Winkelmann W., Zoubek A., Jürgens H., Winkler K., Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. Journal of Clinical Oncology 2002 20 3 776 790 2-s2.0-0036467661 10.1200/JCO.20.3.776 (Pubitemid 34111386)
5. Rubin L. L., de Sauvage F. J., Targeting the Hedgehog pathway in cancer. Nature Reviews Drug Discovery 2006 5 12 1026 1033 2-s2.0-33751549095 10.1038/nrd2086 (Pubitemid 44835129)
6. Jiang J., Hui C. C., Hedgehog signaling in development and cancer. Developmental Cell 2008 15 6 801 812 2-s2.0-57049089995 10.1016/j.devcel.2008. 11.010
7. Berman D. M., Karhadkar S. S., Maitra A., De Oca R. M., Gerstenblith M. R., Briggs K., Parker A. R., Shimada Y., Eshleman J. R., Watkins D. N., Beachy P. A., Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003 425 6960 846 851 2-s2.0-0242268525 10.1038/nature01972 (Pubitemid 37351469)
8. Dierks C., Grbic J., Zirlik K., Beigi R., Englund N. P., Guo G., Veelken H., Engelhardt M., Mertelsmann R., Kelleher J. F., Schultz P., Warmuth M., Essential role of stromally induced Hedgehog signaling in B-cell malignancies. Nature Medicine 2007 13 8 944 951 2-s2.0-34547683699 10.1038/nm1614 (Pubitemid 47222041)
9. Hegde G. V., Peterson K. J., Emanuel K., Mittal A. K., Joshi A. D., Dickinson J. D., Kollessery G. J., Bociek R. G., Bierman P., Vose J. M., Weisenburger D. D., Joshi S. S., Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Molecular Cancer Research 2008 6 12 1928 1936 2-s2.0-57749086958 10.1158/1541-7786.MCR-08-0142
10. Karhadkar S. S., Bova G. S., Abdallah N., Dhara S., Gardner D., Maitra A., Isaacs J. T., Berman D. M., Beachy P. A., Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004 431 7009 707 712 2-s2.0-6044243650 10.1038/nature02962 (Pubitemid 39382619)
11. Thayer S. P., Di Magliano M. P., Heiser P. W., Nielsen C. M., Roberts D. J., Lauwers G. Y., Qi Y. P., Gysin S., Fernández-del Castillo C., Yajnik V., Antoniu B., McMahon M., Warshaw A. L., Hebrok M., Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003 425 6960 851 856 2-s2.0-0242270878 10.1038/nature02009 (Pubitemid 37355945)
12. Yauch R. L., Gould S. E., Scales S. J., Tang T., Tian H., Ahn C. P., Marshall D., Fu L., Januario T., Kallop D., Nannini-Pepe M., Kotkow K., Marsters J. C. Jr., Rubin L. L., De Sauvage F. J., A paracrine requirement for Hedgehog signalling in cancer. Nature 2008 455 7211 406 410 2-s2.0-52149119128 10.1038/nature07275
13. Dahmane N., Lee J., Robins P., Heller P., Altaba A. R., Activation of the transcription factor Gli1 and the sonic Hedgehog signalling pathway in skin tumours. Nature 1997 389 6653 876 881 2-s2.0-0030844141 10.1038/39918 (Pubitemid 27462984)
14. Undén A. B., Zaphiropoulos P. G., Bruce K., Toftgård R., Ståhle-Bäckdahl M., Human patched (PTCH) mRNA is overexpressed consistently in tumor cells of both familial and sporadic basal cell carcinoma. Cancer Research 1997 57 12 2336 2340 2-s2.0-0030990735 (Pubitemid 27255884)
15. Lee Y., Miller H. L., Jensen P., Hernan R., Connelly M., Wetmore C., Zindy F., Roussel M. F., Curran T., Gilbertson R. J., McKinnon P. J., A molecular fingerprint for medulloblastoma. Cancer Research 2003 63 17 5428 5437 2-s2.0-0141816821 (Pubitemid 37139861)
16. Raffel C., Jenkins R. B., Frederick L., Hebrink D., Alderete B., Fults D. W., James C. D., Sporadic medulloblastomas contain PTCH mutations. Cancer Research 1997 57 5 842 845 2-s2.0-0031036694 (Pubitemid 27098006)
17. Kronenberg H. M., Developmental regulation of the growth plate. Nature 2003 423 6937 332 336 2-s2.0-0038687536 10.1038/nature01657 (Pubitemid 40852707)
18. St-Jacques B., Hammerschmidt M., McMahon A. P., Indian Hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes and Development 1999 13 16 2072 2086 2-s2.0-0033567213 (Pubitemid 29407348)
19. Ho L., Stojanovski A., Whetstone H., Wei Q. X., Mau E., Wunder J. S., Alman B., Gli2 and p53 cooperate to regulate IGFBP-3-mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors. Cancer Cell 2009 16 2 126 136 2-s2.0-67651152911 10.1016/j.ccr.2009.05.013
20. Hopyan S., Gokgoz N., Poon R., Gensure R. C., Yu C., Cole W. G., Bell R. S., Jüppner H., Andrulis I. L., Wunder J. S., Alman B. A., A mutant PTH/PTHrP type I receptor in enchondromatosis. Nature Genetics 2002 30 3 306 310 2-s2.0-0036509934 10.1038/ng844
21. Tiet T. D., Alman B. A., Developmental pathways in musculoskeletal neoplasia: involvement of the Indian Hedgehog-parathyroid hormone-related protein pathway. Pediatric Research 2003 53 4 539 543 2-s2.0-0037383498 10.1203/01.PDR.0000054688.93486.18 (Pubitemid 36406720)
22. Tiet T. D., Hopyan S., Nadesan P., Gokgoz N., Poon R., Lin A. C., Yan T., Andrulis I. L., Alman B. A., Wunder J. S., Constitutive Hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. The American Journal of Pathology 2006 168 1 321 330 2-s2.0-30344434306 10.2353/ajpath.2006.050001 (Pubitemid 43062583)
23. Lo W. W., Wunder J. S., Dickson B. C., Campbell V., McGovern K., Alman B. A., Andrulis I. L., Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma. Cancer 2014 120 4 537 547 10.1002/cncr.28439
24. Cox D. R., Oakes D., Analysis of Survival Data 1984 New York, NY, USA Chapman & Hall/CRC
25. Cox D. R., Regression models and life-tables. Journal of the Royal Statistical Society B: Methodological 1972 34 2 187 220
26. Heinze G., Schemper M., A solution to the problem of monotone likelihood in Cox regression. Biometrics 2001 57 1 114 119 2-s2.0-0035099124 (Pubitemid 32200144)
27. Ng J. M. Y., Curran T., The Hedgehog's tale: developing strategies for targeting cancer. Nature Reviews Cancer 2011 11 7 493 501 2-s2.0-80955181031 10.1038/nrc3079
28. Warzecha J., Göttig S., Chow K. U., Brüning C., Percic D., Boehrer S., Brude E., Kurth A., Inhibition of osteosarcoma cell proliferation by the Hedgehog-inhibitor cyclopamine. Journal of Chemotherapy 2007 19 5 554 561 2-s2.0-36549057017 (Pubitemid 350177967)
29. Hirotsu M., Setoguchi T., Sasaki H., Matsunoshita Y., Gao H., Nagao H., Kunigou O., Komiya S., Smoothened as a new therapeutic target for human osteosarcoma. Molecular Cancer 2010 9, article 5 2-s2.0-76849102604 10.1186/1476-4598-9-5
30. Nagao H., Ijiri K., Hirotsu M., Ishidou Y., Yamamoto T., Nagano S., Takizawa T., Nakashima K., Komiya S., Setoguchi T., Role of GLI2 in the growth of human osteosarcoma. Journal of Pathology 2011 224 2 169 179 2-s2.0-79955821961 10.1002/path.2880
31. Yang W., Liu X., Choy E., Mankin H., Hornicek F. J., Duan Z., Targeting Hedgehog-GLI-2 pathway in osteosarcoma. Journal of Orthopaedic Research 2013 31 3 502 509 10.1002/jor.22230
32. Mohseny A. B., Cai Y., Kuijjer M., Xiao W., van den Akker B., de Andrea C. E., Jacobs R., Dijke P. T., Hogendoorn P. C., Cleton-Jansen A. M., The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma. European Journal of Cancer 2012 48 18 3429 3438 10.1016/j.ejca.2012.06.018
33. Mori Y., Okumura T., Tsunoda S., Sakai Y., Shimada Y., Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Oncology 2007 70 5 378 389 2-s2.0-33846060232 10.1159/000098111
34. You S., Zhou J., Chen S., Zhou P., Lv J., Han X., Sun Y., PTCH1, a receptor of Hedgehog signaling pathway, is correlated with metastatic potential of colorectal cancer. Upsala Journal of Medical Sciences 2010 115 3 169 175 2-s2.0-77954880696 10.3109/03009731003668316
35. Fletcher C. D. M., Unni K. K., Mertens F., Pathology and Genetics of Tumours of Soft Tissue and Bone 2002 4 Lyon, France World Health Organization